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Abstract (133) 34 
Knowledge of the host factors required for norovirus replication has been hindered 35 
by the challenges associated with culturing human noroviruses. We have combined 36 
proteomic analysis of the viral translation and replication complexes with a CRISPR 37 
screen, to identify host factors required for norovirus infection. The core stress 38 
granule component G3BP1 was identified as a host factor essential for efficient 39 
human and murine norovirus infection, demonstrating a conserved function across 40 
the Norovirus genus. Furthermore, we show that G3BP1 functions in the novel 41 
paradigm of viral VPg-dependent translation initiation, contributing to the assembly of 42 
translation complexes on the VPg-linked viral positive sense RNA genome by 43 
facilitating ribosome recruitment. Our data uncovers a novel function for G3BP1 in 44 
the life cycle of positive sense RNA viruses and identifies the first host factor with 45 
pan-norovirus pro-viral activity. 46 
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Introduction: 53 
Positive sense RNA viruses rely heavily on host cell factors for all aspects of their life 54 
cycle. They replicate on host derived membranous vesicles that are induced 55 
following viral infection, the formation of which requires the activity of key membrane 56 
bound viral enzymes (Altan-Bonnet, 2017). Within the membrane bound viral 57 
replication complex, translation of the viral genome and the synthesis of new viral 58 
RNA occurs in a highly coordinated process. Positive sense RNA viruses have 59 
evolved novel gene expression mechanisms that enable them to overcome the 60 
genome size limitations that accompany error-prone replication and which might 61 
restrict their overall coding capacity (Firth and Brierley, 2012). In addition, viral 62 
modification of the host cell translation machinery often provides a competitive 63 
advantage allowing for the efficient translation of viral RNA in an environment where 64 
competing cellular RNAs are in abundance (McCormick and Khaperskyy, 2017).  65 
This ability to compete with cellular RNAs is particularly important for the initiation of 66 
infection where the incoming viral genome may be present at only a single copy per 67 
cell. 68 
We have previously described a novel paradigm of viral translation that relies on the 69 
interaction of host translation initiation factors with a virus-encoded protein (VPg), 70 
covalently linked to the 5’ end of the genome of members of the Caliciviridae family 71 
of positive sense RNA viruses (Chaudhry et al., 2006; Chung et al., 2014; 72 
Goodfellow et al., 2005; Hosmillo et al., 2014; Leen et al., 2016). Unlike the 22-73 
amino acid VPg peptides from picornaviruses, the VPg protein linked to the genomes 74 
of caliciviruses is significantly larger and is essential for the translation of viral RNA 75 
and viral RNA infectivity (Goodfellow, 2011). 76 
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Human noroviruses (HuNoV) and sapoviruses (HuSaV) are enteropathogenic 78 
members of the Caliciviridae family of positive sense RNA viruses, and together 79 
cause >20% of all cases of gastroenteritis (GE). They are also a significant cause of 80 
morbidity and mortality in the immunocompromised; individuals with genetic immune-81 
deficiencies, cancer patients undergoing treatment and transplant recipients often 82 
experience chronic norovirus infections lasting months to years (van Beek et al., 83 
2016). The economic impact of HuNoV is estimated to be at least ~$4.2 billion in 84 
direct health care costs, with wider societal costs of ~$60 billion (Bartsch et al., 85 
2016). Despite their socioeconomic impact, we have, until very recently lacked a 86 
detailed understanding of much of the norovirus life cycle and many significant 87 
questions remain unanswered. HuNoV replicons (Chang et al., 2006), a murine 88 
norovirus that replicates in cell culture (Karst et al., 2003; Wobus et al., 2004) and 89 
the recent B cell (Jones et al., 2014), stem-cell derived organoid (Ettayebi et al., 90 
2016) and zebrafish larvae infection models (Van et al., 2019), have all provided 91 
invaluable tools to dissect the norovirus life cycle. However, due to the technical 92 
limitations associated with many of these experimental systems, in comparison to 93 
other positive sense RNA viruses, our knowledge of the intracellular life of 94 
noroviruses is significantly lacking (reviewed in Thorne and Goodfellow, 2014).  95 
In the current study, we have combined three independent unbiased approaches to 96 
identify host factors involved in the norovirus life cycle. Combining experimental 97 
systems that incorporated both murine and human noroviruses, allowed the 98 
identification of cellular factors for which the function is likely conserved across the 99 
Norovirus genus.  By combining three complimentary approaches, we identify the 100 
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host protein G3BP1 as a critical host factor required for norovirus VPg-dependent 101 
translation, identifying a new role for G3BP1 in virus-specific translation. 102 
Results: 103 
Comparative analysis of the norovirus translation initiation complex. 104 
The MNV and the prototype HuNoV Norwalk virus (NV) VPg proteins are covalently 105 
linked to the viral genome via the highly conserved tyrosine residue within an N-106 
terminal DEEYD/E motif found in all calicivirus VPg proteins (Figure 1A). In addition, 107 
the norovirus VPg proteins contain a highly conserved C-terminal domain which we 108 
have shown to be necessary and sufficient for binding to the translation initiation 109 
factor eIF4G via an interaction that requires a highly conserved phenylalanine 110 
residue (Figure 1A) (Chung et al., 2014; Leen et al., 2016). Using affinity purification 111 
on m7-GTP sepharose, we confirmed that the NV VPg protein, as produced during 112 
authentic virus replication in a NV replicon bearing cell line, interacts with the cap-113 
binding complex eIF4F (Figure 1B). Components of the eIF4F complex, namely the 114 
eIF4E cap-binding protein, the eIF4A helicase and the eIF4GI scaffold protein, along 115 
with poly-A binding protein (PABP) and eIF3 subunits, were readily purified on m7-116 
GTP sepharose, whereas GAPDH was not. In NV-replicon containing cells, mature 117 
VPg was also enriched on m7-GTP sepharose but the NS3 protein, known to have 118 
RNA binding and helicase activity (Li et al., 2018), was not. Furthermore, we 119 
demonstrated that transfection of GFP-tagged versions of either the MNV or NV VPg 120 
proteins into 293T cells allowed for the affinity purification of eIF4F components and 121 
that mutations in the eIF4G binding domain of VPg reduced this association (Figure 122 
1C).  123 
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We next used quantitative mass spectrometry of the affinity purified complexes 125 
isolated from cells transfected with the GFP-Tagged VPg proteins to identify host 126 
factors specifically enriched on the norovirus VPg protein (Figure 1D, Figure 1-figure 127 
supplement 1 and Supplementary file 1). Most of the proteins identified were 128 
components of the host cell translation complex including ribosomal proteins, 129 
translation initiation factors and host RNA binding proteins. These data agrees with 130 
but significantly extend our previous observations using a less sensitive multi-step 131 
affinity purification approach to characterise host factors associated with the MNV 132 
VPg protein only (Chaudhry et al., 2006; Chung et al., 2014).   In addition, we 133 
identified hnRNPA1 which we have previously shown to act in norovirus genome 134 
circularization (López-Manríquez et al., 2013). YBX1, DDX3 and several other 135 
proteins that we have previously found to interact with the 5’ end of the viral RNA 136 
(Vashist et al., 2012b) were also enriched on VPg (Figure 1-figure supplement1). To 137 
validate a select number of these interactions and to assess whether the interaction 138 
of VPg with eIF4G is required for their association with VPg, we performed western 139 
blot analysis of complexes purified from cells transfected with either the WT or 140 
eIF4G-binding mutants (Figure 1E). Except for YBX1, the association of all proteins 141 
tested were reduced by the introduction of eIF4G-binding site mutations into the 142 
MNV VPg protein. Together, these data extend our previous observations and 143 
confirm that the norovirus VPg proteins interact with a complex network of host 144 
factors, many of which have been implicated in the host cell translation initiation 145 
process. 146 
 147 
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Determination of the norovirus replication complex proteome. 148 
To further identify the components of the norovirus translation and replication 149 
complex, as formed during authentic viral replication in highly permissive cells, we 150 
utilised two recombinant infectious MNV strains that carried epitope purification tags 151 
within the NS1/2 or NS4 proteins (McCune et al., 2017) (Figure 2A). The insertion 152 
positions were previously identified using a transposon based mutagenesis screen 153 
as sites that tolerate insertions, without compromising virus viability (Thorne et al., 154 
2012). Our approach was somewhat analogous to that recently published for 155 
coronaviruses (V'kovski et al., 2019) but instead used stable isotope labelling of 156 
permissive cells and the FLAG affinity purification tag rather than proximity labelling. 157 
Unlabelled or stable isotope labelled highly permissive BV2 microglial cells were 158 
infected with either wild type MNV or the equivalent virus carrying the FLAG epitope 159 
purification tag in either NS1/2 or NS4, and the viral replication complex was purified. 160 
The experiment was performed three times by swapping the labelled derivatives of 161 
arginine and lysine as described in the materials and methods. Silver stain of the 162 
purified complexes confirmed the presence of the bait proteins, with both the 163 
uncleaved and cleaved forms of NS1/2 and NS2 being highly enriched (Figure 2B). 164 
As expected, complexes purified from NS1/2-Flag virus infected cells co-purified 165 
untagged NS4 and vice versa (Figure 2B), as we have previously shown these 166 
proteins to interact to form a complex (Thorne et al., 2012). Western blot analysis of 167 
the purified complexes confirmed that viral non-structural and structural proteins 168 
were specifically enriched in the purified complexes, including NS5 (VPg)-containing 169 
precursors (Figure 2C). We noted that anti-NS4 monoclonal antibody was unable to 170 
detect protein in the extracts prior to enrichment, which most likely reflected the 171 
limited sensitivity of the antibody. Quantitative mass spectrometry of the purified 172 
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complexes allowed the identified of viral and cellular proteins enriched in the 173 
complex (Figure 2D and Supplementary file 2).  174 
As expected, all viral proteins, including the VF1 protein product of ORF4, an innate 175 
immune antagonist (Bailey et al., 2011), were enriched in the viral replication 176 
complex. There was a significant correlation between the relative enrichment of 177 
proteins identified using NS1/2 and NS4 (Spearman correlation of 0.8832), fitting 178 
with our prior knowledge that both proteins form a complex during viral replication 179 
(Thorne et al., 2012). Ontology analysis indicated that proteins involved in vesicle 180 
transport and fatty acid metabolism were significantly enriched (Figure 2-figure 181 
supplement 1 and Supplementary file 3), fitting with previous observations that the 182 
viral replication complex is associated with cytoplasmic membranous structures 183 
(Cotton et al., 2017; Hyde and Mackenzie, 2010; Hyde et al., 2009). Several host 184 
proteins previously identified in a variety of biochemical and genetic screens were 185 
enriched (Figure 2-figure supplement1 and Supplementary file 3) providing additional 186 
confidence that the approach identified biologically relevant interactions. We noted 187 
that the VapA and the paralogue VapB, which we have recently identified as binding 188 
to the NS1/2 protein (McCune et al., 2017), were both highly enriched.  189 
We observed that NS4 failed to enrich mature VPg, instead purifying only the 190 
polyprotein cleavage intermediate NS4/5(VPg) (Figure 2C & S2.2). In contrast, 191 
NS1/2 effectively pulled down mature VPg (Figure 2C & S2.2). Consistent with this, 192 
NS1/2 enriched the VPg binding partner eIF4G more than 2-fold, while pulldown of 193 
NS4 resulted in no eIF4G enrichment, likely indicating that the NS4/5 (VPg) 194 
precursor cannot effectively function in translation initiation (Figure 2-figure 195 
supplement 2). This is consistent with a previous observation that binding of C-196 
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terminal VPg fusion proteins to eIF4G is inhibited {Leen:2016gt}, but may further 197 
suggest that the function of VPg is also altered when present as an N-terminal fusion 198 
with NS4. Comparison with the proteomics data obtained using VPg as a bait protein 199 
(Figure 1) showed some degree of overlap with our replication complex proteome 200 
data (Figure 2-figure supplement 2). Consistent with our observations with the well-201 
established VPg partner eIF4G, most host factors identified using VPg were enriched 202 
by >2-fold using only the NS1/2 tagged virus, and not the NS4-tagged virus. 203 
Ontology analysis of host factors enriched by both VPg and NS1/2 more than 2-fold 204 
reveals a cross-section of the replication complex proteome dedicated to translation, 205 
and RNA metabolism (Figure 2-figure supplement 2 and Supplementary file 3). One 206 
protein was enriched by VPg, NS1/2, and NS4 – the core stress granule protein 207 
G3BP1 (Figure 2-figure supplement 2). 208 
 209 
Identification of host factors required for norovirus infection using a CRISPR- 210 
knockout screen.  211 
A high density CRISPR library screen was undertaken to identify genes that 212 
contribute to the norovirus life cycle. The Brie library (Doench et al., 2016) was 213 
selected due to the reduced off-target effects relative to previously described 214 
CRISPR libraries used for norovirus studies (Haga et al., 2016; Orchard et al., 2016). 215 
In addition, to minimise the impact of gRNAs that may have deleterious effects on 216 
long term cell viability and to increase our ability to detect genes that may be 217 
important, but not essential, for norovirus-induced cell death, the infection was 218 
reduced to 24 hours as compared to 2-10 days post infection in previous studies. 219 
BV2-Cas9 expressing cells were infected with lentiviruses carrying the Brie gRNA 220 
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library carrying 78,637 independent guide RNAs to 19,674 genes (Doench et al., 221 
2016). The transduced cells were then infected with two MNV strains, CW3 and 222 
CR6, which cause acute and persistent infections in immunocompetent mice 223 
respectively (Nice et al., 2012; Thackray et al., 2007), and guide RNA abundance 224 
compared to mock infected cells at 24 hours post infection as illustrated in Figure 3A.  225 
Genes that were enriched by STARS analysis following MNV infection represent 226 
putative pro-viral factors which when disrupted, resulting in slower cell death, 227 
whereas those with a negative STARS value represent putative anti-viral factors 228 
where virus-induced cell death has occurred quicker, resulting in their 229 
underrepresentation in the final pool of cells. MNV-CR6 infection resulted in 212 230 
genes being enriched and 42 being negatively selected (Figure 3B), whereas for 231 
MNV-CW3 279 and 18 genes were positively and negatively selected respectively 232 
(Figure 3B). In most cases, there was a clear correlation between the datasets 233 
obtained using either strain (Figure 3C). STARS analysis was used to ranks genes 234 
with positive and negative values with an FDR value less than 0.05 (Supplementary 235 
file 4). In both screens, the MNV receptor Cd300lf was the most highly positively 236 
selected gene identified, in agreement with previous reports (Haga et al., 2016; 237 
Orchard et al., 2016). The previously characterised pro-viral MNV gene VapA 238 
(McCune et al., 2017) was also identified in both screens (Supplementary file 4). The 239 
second most highly enriched gene was G3BP1, a gene also identified in one of the 240 
two previous CRISPR screens performed on norovirus infected cells (Orchard et al., 241 
2016). 242 
Comparing the CRISPR data obtained in this study using two divergent strains of 243 
MNV showed a high degree of overlap, with 89 common pro-viral hit and 5 common 244 
anti-viral hits (Supplementary file 4). However comparison with the previous reported 245 
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CRISPR screen used to identify the MNV receptor (Orchard et al., 2016) showed 246 
only 7 proviral hits for CW3 and 8 for CR6, of which only 4 were common for both 247 
strains across all screens (Supplementary file 4). The 4 genes identified were the 248 
MNV receptor CD300lf, the stress granule component G3BP1, the histone 249 
methytransferase Kmt2d and Smarce1, which encodes an actin dependent regulator 250 
of chromatin. The discrepancy between the screens performed here and those in 251 
previous studies likely reflects the experimental conditions under which the screens 252 
were undertaken i.e. 24 hours of infection vs 2-3 days in the previous screens. The 253 
previous screen was performed under much more stringent conditions that were 254 
unlikely to identify proteins that play a role in the norovirus life cycle but are not 255 
essential. Pathway over-representation analysis {Liao:2019fn} of the genes pro-viral 256 
genes identified in the CRISPR screens performed in this study highlighted mRNA 257 
processing, RNA splicing and methylation as the three most highly represented gene 258 
ontology (GO) terms (Supplementary file 4). The gene encoding PTBP1, 259 
polypyrimidine tract binding protein, was one of the genes identified in these 260 
enriched GO terms. PTBP1 is a protein we have previously shown to bind to a 3’ 261 
pyrimidine-rich stretch in the MNV genome which is important for viral pathogenesis 262 
{Bailey:2010fz}. The interaction of PTBP1 with the viral 3’ end also facilitates the 263 
recruitment of PTBP1 to the viral replication complex where it contributes to an as 264 
yet undefined aspect of the norovirus life cycle {Vashist:2012ke}. 265 
A cross-comparison of the data obtained from all three approaches allowed us to 266 
identify several host proteins that were common to all screens (Supplementary file 267 
5). G3BP1, the core stress granule component was identified in all three screens as 268 
a potential host factor essential for norovirus infection. G3BP1 was found to be 269 
associated with the MNV and NV VPg proteins (Figure 1D), enriched in viral 270 
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replication complexes purified using either NS1/2 or NS4 flag tagged viruses (Figure 271 
2D) and identified in a CRISPR screen using two different MNV strains as a putative 272 
pro-viral factor involved in the norovirus life cycle (Figure 3C). 273 
 274 
G3BP1 is essential for murine norovirus replication 275 
To validate the importance of G3BP1 in the norovirus life cycle we generated G3BP1 276 
deficient BV2 cell lines (Figure 4A) and examined the impact of G3BP1 ablation on 277 
MNV infection. Western blotting confirmed the loss of G3BP1 in the three lines 278 
tested and we noted that at in some cases, a concomitant increase in G3BP2 279 
expression was observed as has been previously noted (Kedersha et al., 2016). A 280 
clear defect was observed in the ability to replicate to produce infectious virus in 281 
three independently selected G3BP1 cell lines (Figure 4B). This effect was mirrored 282 
by an inability to induce cytopathic effect leading to virus-induced cell death (Figure 283 
4C&D). In contrast, the ability of encephalomyocarditis virus (EMCV) to infect and 284 
cause cell death was unaffected by the deletion of G3BP1(Figure 4C&D). These 285 
data confirm that cells lacking G3BP1 are highly resistant to norovirus infection. 286 
 287 
G3BP1 is essential for human norovirus replication in cell culture 288 
To determine if the G3BP1 was also essential for HuNoV, we examined the impact 289 
of loss of G3BP1 on human norovirus replication in cell culture using the Norwalk 290 
virus replicon.  To establish the experimental system, we first confirmed that the 291 
presence of VPg on the 5’ end of the Norwalk RNA was essential for the replication 292 
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of the replicon RNA and for the capacity to form G418 resistant colonies. 293 
Transfection of replicon RNA, purified from replicon containing cells, into BHK cells 294 
readily resulted in the formation of antibiotic resistant cell colonies (Figure 5A). In 295 
contrast, RNA that was proteinase K treated prior to transfection was unable to 296 
produce replicon containing colonies.  Transfection of replicon RNA into wild type 297 
U2OS osteosarcoma cells allowed the formation of replicon-containing colonies, 298 
although the efficiency of formation was significantly less than that seen in BHK cells 299 
(Figure 5B). CRISPR modified U2OS cells that lacked G3BP1 (Kedersha et al., 300 
2016)  were unable to support NV replication, as evident by the lack of antibiotic 301 
resistant colonies (Figure 5B). To further examine the role of G3BP1 in human 302 
Norwalk virus replication, WT or G3BP1 deficient U2OS cells were transfected with 303 
NV replicon VPg-linked RNA, and RNA synthesis monitored overtime following the 304 
addition of G418. While a significant increase in NV viral RNA levels was seen in WT 305 
U2OS cells, those lacking G3BP1 were completely unable to support NV RNA 306 
synthesis (Figure 5C). We further validated these observations by transfection of the 307 
NV replicon in murine BV2 microglial cells which were able to support HuNoV 308 
replication by the formation of small microcolonies of antibiotic resistant cells (Figure 309 
5D). In the absence of G3BP1 the formation of antibiotic resistant microcolonies was 310 
completely ablated and then subsequently restored in G3BP1 cells engineered to 311 
express the wild type version of G3BP1 (Figure 5D). These data indicate that like for 312 
MNV, G3BP1 is essential for human Norwalk virus replication. 313 
 314 
The RNA-binding domain of G3BP1 is required for its function in the norovirus 315 
life cycle. 316 
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To confirm the role of G3BP1 in the norovirus life cycle we examined the ability of full 317 
length and truncated versions of G3BP1 to restore norovirus replication in G3BP1 318 
knockout cells. A mouse BV2 G3BP1 knockout cell line was complemented with 319 
either full length G3BP1 or variants lacking the RGG or both the RGG and RRM 320 
binding domains (Figure 6A) and the impact on viral replication assessed. 321 
Complementation with full length murine G3BP1 restored the ability of MNV to 322 
induce cell death (Figure 6B) and to produce infectious virus (Figure 6C) back to 323 
near wild type levels. In contrast, complementation with a variant carrying a deletion 324 
of the RGG domain resulted in limited complementation, and deletion of both the 325 
RGG and RRM domains together resulted in complete loss of complementation 326 
capacity (Figure 6B&C). These data confirm that the RNA binding domains of 327 
G3BP1 are essential for its function in the norovirus life cycle. 328 
To further define the role of G3BP1 in the norovirus life cycle and to confirm that the 329 
function of G3BP1 was downstream of virus binding and viral entry, we therefore 330 
bypassed the entry phase of the infection process and transfected MNV VPg-linked 331 
RNA into WT and two independently generated BV2 G3BP1 cell lines and 332 
examined the impact on norovirus replication. Transfection of MNV viral VPg-linked 333 
RNA into WT cells resulted in high yields of infectious virus (Figure 7A) and viral 334 
proteins (Figure 7C). The levels of infectivity obtained following transfection of 335 
G3BP1 cell lines with MNV viral RNA was comparable to that obtained in WT cells 336 
in the presence of the nucleoside analogue 2'-C-methylcytidin (2CMC), a known 337 
inhibitor of the norovirus RNA polymerase (Rocha-Pereira et al., 2012; 2013) (Figure 338 
7A). No viral proteins were detected in either of the G3BP1 cell lines suggesting a 339 
defect at a very early stage in the viral life cycle (Figure 7C). Transfection of VPg-340 
linked RNA into the G3BP1 cell lines reconstituted with WT G3BP1 restored the 341 
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ability to produce infectious virus (Figure 7B) and the production of viral proteins 342 
(Figure 7D). A minor increase in viral infectivity was observed in the G3BP1 cell line 343 
reconstituted with the RGG construct producing viral titres that were higher than 344 
those obtained from the WT complemented line in the presence of 2CMC, 345 
suggesting low levels of viral replication (Figure 7B). However, the levels of viral 346 
proteins produced in this line was below the limit of detection by western blot (Figure 347 
7D). These data confirm that G3BP1 is required for a post entry stage of the 348 
norovirus life cycle and that in the absence of G3BP1 no norovirus replication was 349 
observed within the sensitivity of the assay used. 350 
 351 
G3BP1 is required for, or prior to, viral negative strand RNA synthesis  352 
To define the precise role of G3BP1 in the early stages of the virus life cycle, we 353 
used strand-specific RT-qPCR to quantify the levels of viral positive and negative 354 
sense RNA in WT and G3BP1 cell lines following infection with MNV. As a control, 355 
2CMC was included following virus inoculation as illustrated in the experimental time 356 
line (Figure 8A). The production of viral positive sense RNA was reduced to 357 
background levels in the absence of G3BP1, comparable to levels observed when 358 
the 2CMC was present during the infection (Figure 8B). Viral negative sense RNA 359 
synthesis was also reduced to below the detection limit of the assay in G3BP1 cell 360 
lines (Figure 8C). Surprisingly, we were able to detect an ~5 fold increase in viral 361 
negative sense RNA production at 6 hours post infection of WT cells in the presence 362 
of 2CMC, which, given that 2CMC was added after the inoculation phase (Figure 363 
8B), likely represents the first round of viral negative sense RNA synthesis, 364 
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confirming the sensitivity of the assay. Addition of 2CMC during the inoculation 365 
phase reduced this background levels (data not shown).  366 
Similar results were obtained following transfection of viral RNA into cells to bypass 367 
the entry phase; viral positive and negative sense RNA synthesis was near (or 368 
below) the sensitivity of the assay following transfection of viral VPg-linked RNA into 369 
two independent G3BP1 cell lines (Figure 8D & E). Complementation with WT 370 
G3BP1, but not the mutant forms lacking the RNA binding domains, also restored 371 
viral positive and negative sense RNA synthesis (Figure 8F & G). We did not detect 372 
viral positive or negative sense RNAs in the RGG complemented cell line, despite 373 
the presence of low levels of viral infectivity (Figure 7B).  This discrepancy likely 374 
reflects the relative sensitivities of the assays and the nature of the strand specific 375 
qPCR assay which requires low levels of RNA input to maintain strand specificity.  376 
Together these data suggest that the function of G3BP1 is prior to, or at the level of 377 
viral negative sense RNA synthesis, with the most logical steps being either viral 378 
RNA translation or the formation of viral replication complexes. 379 
 380 
G3BP1 is required for the association of VPg with ribosomal proteins. 381 
We have previously shown that norovirus VPg interacts with eIF4G to recruit 382 
ribosomal subunits and direct viral translation (Chaudhry et al., 2006; Chung et al., 383 
2014). The interaction between VPg and eIF4G occurs via a direct interaction 384 
between the highly conserved C-terminal region in VPg and the central HEAT 385 
domain of eIF4G (Leen et al., 2016) and does not require any additional cellular 386 
cofactors, as a stable complex can be formed between VPg and the eIF4G HEAT 387 
 17 
domain at least in vitro. The interaction between the eIF4G HEAT domain and the 388 
eIF3 complex plays a central role in the recruitment of the 40S ribosomal subunit for 389 
translation initiation (Marcotrigiano:2001uq; Kumar et al., 2016; Villa et al., 2013). 390 
Our proteomics analysis also confirms that the norovirus VPg proteins form a 391 
complex that contains multiple components of the large and small ribosomal subunits 392 
(Figure 1D). It has been established previously that G3BP1 associates with 40S 393 
subunits (Kedersha et al., 2016). To assess a potential role for G3BP1 in the 394 
formation of VPg-driven translation complexes in cells, we examined the ability of 395 
GFP tagged versions of MNV VPg to pull down ribosomal proteins in the presence 396 
and absence of G3BP1. GFP-tagged WT MNV VPg was readily able to pull down 397 
eIF4G, G3BP1 and RpS6, a component of the 40S subunit (Figure 9A). However, in 398 
the absence of G3BP1, the ability to pull down RpS6 and RpS3 was lost (Figure 9A 399 
and Figure 9-figure supplement 1). Furthermore, we found that disruption of the VPg-400 
eIF4G interaction by the introduction of the F123A mutation into the eIF4G binding 401 
domain, also significantly reduced the ability to pull down RpS6, RpS3, as well as 402 
RpL4, a component of the large ribosomal subunit (Figure 9B and Figure 9-figure 403 
supplement 1). We also observed that upon reconstitution of G3BP1 expression, the 404 
levels of RpS6, RpS3 and RpL4 associated with VPg were enhanced (Figure 9B and 405 
Figure 9-figure supplement 1). We note however that the levels of ribosomal proteins 406 
associated with the GFP-tagged VPg in this assay is relatively low, we think this 407 
reflect the fact that in the context of viral infection where VPg is covalently linked to 408 
viral RNA, secondary interactions between translation initiation factors and the viral 409 
RNA likely stabilise this complex. We have previously seen that the eIF4A protein 410 
binds directly to the 5’ end of the sapovirus genome {Hosmillo:2016fp}. Furthermore, 411 
eIF4G is known to make secondary stabilising interactions with the template RNA 412 
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that are critical for translation initiation {Yanagiya:2009fm}. Therefore we hypothesise 413 
that in the absence of covalently linked viral RNA, the association of VPg with 414 
ribosomal subunits is less robust and therefore less able to be maintained during the 415 
purification process used in the GFP-Trap approach. Therefore, to assess how the 416 
loss of G3BP1 may influence the association of VPg-linked viral RNA with ribosomal 417 
subunits in a more physiologically relevant system, we quantified the amount of viral 418 
VPg-linked RNA bound to ribosomal subunits by RNA-IP. By inclusion of the viral 419 
RNA polymerase inhibitor 2CMC we were able to assess viral RNA association with 420 
ribosomal proteins in the absence of viral RNA synthesis.  We found that in the 421 
absence of G3BP1, the amount of viral RNA associated with the ribosomal subunit 422 
protein RpS3 was decreased (Figure 9C). These data suggest that that G3BP1 likely 423 
contributes in some manner to the association of VPg and viral VPg-linked RNA with 424 
ribosomal subunits. 425 
 426 
G3BP1 is required for efficient polysome loading of norovirus VPg-linked RNA 427 
To assess the impact of G3BP on the translation of viral VPg-linked RNA following 428 
viral infection, we evaluated the impact of loss of G3BP1 on the recruitment of viral 429 
RNA to polysomes under conditions where viral RNA synthesis was inhibited, 430 
namely in the presence of 2CMC. This approach enabled us to assess only the 431 
capacity of the incoming parental viral RNA to assemble into translationally active 432 
complexes, a stage often referred to as the “maiden round” of RNA virus genome 433 
translation. To this aim, cells were infected with MNV in the presence of 2CMC and 434 
polysomes profiling on extracts prepared from cells at 4 and 9 hours post infection 435 
performed (Figure 10A). Quantification of the viral RNA levels in cells in the 436 
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presence of 2CMC confirmed that the absence of G3BP1 has no impact on the 437 
overall levels present at the time points examined (data not shown). We noted that 438 
even in the presence of 2CMC, which inhibits viral RNA synthesis, there was a small 439 
but measurable increase in free 80S ribosomes over time in WT cells but not in cells 440 
lacking G3BP1 (Figure 10A). We have previously found that MNV infection results in 441 
translation shut off  and that this effect is at least partially due to the activity of the 442 
NS6 protease (Emmott et al., 2017). The fact we observed 80S accumulation in WT 443 
cells, even in the absence of viral RNA synthesis, but not in cells lacking G3BP1, 444 
indirectly lead us to suspect that translation of viral RNA had occurred in WT cells, 445 
but was much less efficient in cells lacking G3BP1. Further analyses indicated that 446 
while most ribosome-associated norovirus RNA in WT cells was found in polysomes 447 
containing fractions, less viral RNA was found in ribosome-containing fractions (1-12 448 
in Figure 10A & B) in the absence of G3BP1 and, in comparison to WT cells, very 449 
little viral RNA was found in fractions containing polysomes (Figure 10B). Extending 450 
the fractionation to include the free RNA and ribonucleoprotein complexes at the top 451 
of each gradient confirmed that in the absence of G3BP1 norovirus RNA is less 452 
efficient at assembling into polysomal fractions, suggesting a defect at the level of 453 
viral protein synthesis (Figure 10C). Together these data support the hypothesis that 454 
G3BP1 functions to promote the translation of norovirus VPg-linked RNA, by 455 
facilitating the association with ribosomal subunits and the formation of polysomes 456 
on viral RNA. 457 
 458 
G3BP1 is require for efficient norovirus VPg-dependent translation. 459 
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To further examine a potential role of G3BP1 in norovirus VPg-dependent 460 
translation, cytoplasmic translationally competent extracts were prepared from WT 461 
and G3BP1 cell lines.  In order to ensure comparable overall translation efficiencies 462 
between extracts, RNA generated from a cricket paralysis virus IRES (CrPV) 463 
bicistronic reporter plasmid (a kind gift from Professor Ian Brierley, University of 464 
Cambridge) was used to measure cap-dependent and cap-independent translation 465 
{Wang:2013kh}. The dual luciferase construct was in vitro transcribed, capped and 466 
poly(A) tailed. Renilla luciferase was produced via cap-dependent translation 467 
initiation whilst firefly luciferase was synthesised via cap-independent, CrPV IRES-468 
dependent translation (Figure 11A). Both cap-dependent (Figure 11B) and CrPV 469 
IRES-dependent translation (Figure 11C) were comparable in extracts prepared from 470 
WT and G3BP1 cell lines (Figure 11A).  To compare norovirus VPg-dependent 471 
translation efficiency between WT and G3BP1 lysates, viral VPg-linked RNA was 472 
first extracted from sucrose cushion-purified MNV virions and the presence of VPg 473 
on the viral RNA 5’ end confirmed by resistance to XrnI mediated degradation in vitro 474 
(Figure 11-figure supplement 1 panel A). The translation profile of the purified viral 475 
RNA was further analysed by translation in rabbit reticulocyte lysates in comparison 476 
to in vitro  transcribed viral genomic and sub-genomic RNAs (Figure 11-figure 477 
supplement 1 panel B). We found that norovirus VPg-dependent translation was 478 
reduced in nuclease treated extracts prepared from cells lacking G3BP (Figure 11D). 479 
Quantification of the levels of multiple viral proteins produced over multiple 480 
experiments indicated that translation in nuclease treated extracts was on average 481 
reduced by ~40-50% because of G3BP1 ablation (Figure 11E).   A similar reduction 482 
in in vitro translation was observed across multiple time points (Figure 11-figure 483 
supplement 1 panel C ). This 50% reduction in translation efficiency was also 484 
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consistently observed in extracts that were not nuclease treated, and therefore 485 
contained physiologically relevant levels of cellular mRNAs (Figure 11F & G). These 486 
data further confirm that G3BP1 functions to enhance norovirus VPg-dependent 487 
translation initiation. 488 
 489 
Discussion 490 
In this study, we have used a combination of biochemical and genetic approaches to 491 
identify host factors involved in the norovirus life cycle. Our combined approaches 492 
resulted in the identification of the core stress granule component G3BP1 as a host 493 
protein critical for the replication of both murine and human noroviruses in cell 494 
culture. Furthermore, we determined that G3BP1 plays a key role in the processes of 495 
norovirus VPg-dependent protein synthesis, uncovering a new function for G3BP1 in 496 
facilitating RNA virus genome translation. 497 
The orthogonal approaches used in the current study provide an unprecedented 498 
insight into the identity of host factors with potential roles in the norovirus life cycle. 499 
The detailed proteomic analysis of the viral replication and translation complexes 500 
formed during MNV infection (Figure 2) resulted in the identification of several host 501 
factors with previously identified roles in the MNV life cycle. We focused our efforts 502 
on G3BP1 as it was identified in all three approaches and was also identified in a 503 
CRISPR screen published during this study (Orchard et al., 2016). Furthermore, we 504 
have previously shown that feline calicivirus (FCV), a relative of noroviruses within 505 
the Vesivirus genus, cleaves G3BP1 to inhibit stress granule formation (Humoud et 506 
al., 2016). In contrast, MNV infection does not result in G3BP1 cleavage and instead 507 
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forms cytoplasmic foci the composition of which is distinct from canonical stress 508 
granules (Brocard et al., 2018). 509 
G3BP1 is one member of a group of G3BP proteins (Ras-GTPase-activating protein 510 
(SH3 domain)-binding proteins), referred to as Rasputin in insects, that possess 511 
RNA binding activity and have multiple cellular functions including the regulation of 512 
RNA stability and translation in response to stress. Originally identified as a protein 513 
that interacted with Ras-GTPase activating protein (RasGAP), more than two 514 
decades of research have significantly expanded our knowledge of the 515 
multifunctional role in cellular processes. It is now well accepted that G3BPs play a 516 
role in cancer cell survival, cancer metastasis and invasion, processing of specific 517 
miRNAs and stress granule formation (Reviewed in (Alam and Kennedy, 2019). 518 
Stress granules are dynamic cytoplasmic ribonucleoprotein complexes that form 519 
rapidly under stress conditions and within which cellular RNAs are stored in stalled 520 
translation complexes (Protter and Parker, 2016). In the context of viral infection, 521 
numerous studies have suggested that many, if not all, viruses must interact in some 522 
manner with stress granules as there is growing evidence that the formation of 523 
cytoplasmic stress granules is part of the anti-viral defence mechanism (Reviewed in 524 
(McCormick and Khaperskyy, 2017). Some viruses interact with stress granules to 525 
promote viral replication (Cristea et al., 2010; Kim et al., 2016; Panas et al., 2014; 526 
2012) whereas some do so to counteract the inhibitory effect of stress granules on 527 
the translation of viral RNA (Panas et al., 2015; White et al., 2007).  528 
Our data suggests that G3BP1 plays a key role in promoting the translation of 529 
norovirus VPg-linked viral RNA. Positive sense RNA viruses have evolved 530 
mechanisms to ensure the efficient translation of their viral genomic RNAs in the 531 
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presence of high concentrations of competing cellular RNAs. These mechanisms 532 
include the use of internal ribosome entry site elements (IRES), modified cap-533 
dependent mechanisms (Firth and Brierley, 2012; Jaafar and Kieft, 2019)  and the 534 
ability to target the host cell translation machinery to generate an environment where 535 
viral RNA translation is favoured over cellular capped RNAs (Walsh et al., 2013). 536 
G3BP1 is thought to associate primarily with free 40S subunits (Kedersha et al., 537 
2016). Our data supports a hypothesis whereby the association of G3BP1 with 40S 538 
ribosomal subunits somehow stabilises the recruitment of a translation initiation 539 
complex to the 5’ end of the VPg-linked viral RNA genome, promoting VPg-540 
dependent translation and thereby uncovering a new function in virus specific 541 
translation. The mechanism by which G3BP1 contributes to this process has yet to 542 
be fully explored but our data supports the hypothesis that G3BP1 directly or 543 
indirectly promotes the recruitment of ribosomal subunits to VPg-driven translation 544 
complexes. The RGG motif of G3BP1 is known to be essential for the association 545 
between G3BP1 and 40S subunits as well as the ability to from stress granules, 546 
whereas data would suggest that the RRM may play a regulatory role (Kedersha et 547 
al., 2016). These domains were also required for the function of G3BP1 in the 548 
norovirus life cycle (Figure 6) confirming that the G3BP1 association with 40S is 549 
important for its role in promoting norovirus VPg-dependent translation. Importantly, 550 
RGG domains are known to have many functions (Thandapani et al., 2013) and 551 
therefore in the context of G3BP1 function in the norovirus life cycle, may also 552 
contribute to unknown interactions that promote norovirus translation. Previous work 553 
on alphaviruses have shown that G3BP1 is sequestered by binding to the nsP3 554 
protein (Panas et al., 2012; 2014; 2015). Furthermore, this interaction occurs via an 555 
FGDF motif also found in other viral proteins including the ICP8 protein of herpes 556 
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simplex virus (Panas et al., 2015). While the MNV VPg protein has a similar motif 557 
FGDGF (Figure 1A), this motif is not conserved in the GI Norwalk virus VPg protein. 558 
Therefore, our data suggest that the interaction of VPg with G3BP1 is not direct, 559 
fitting with our observation that this interaction is reduced by mutations in the eIF4G 560 
binding domain (Figure 1A and Figure 9B.)  While our data fit with a primary role for 561 
G3BP1 in norovirus translation, we are unable to exclude the possibility that G3BP1 562 
plays other roles in the viral life cycle. Recent studies have confirmed that G3BP1 is 563 
enriched at sites of viral RNA synthesis (Brocard et al., 2018; Fritzlar et al., 2019) so 564 
it is possible that G3BP1 makes multiple contacts between the 40S subunit and viral 565 
RNA genome directly.  These additional contacts, may further promote viral VPg-566 
dependent translation and/or another aspect of the viral life cycle. 567 
The technical challenges associated with studying human norovirus replication in cell 568 
culture have limited the experimental approaches we could use to validate the role of 569 
G3BP1 in human norovirus translation. However, our results have clearly 570 
demonstrated that in the absence of G3BP1, human Norwalk virus is unable to 571 
replicate or form replicon-containing colonies. Furthermore we were able to show 572 
that BV2 murine microglial cells support the replication of the HuNoV GI replicon, 573 
albeit it to a lesser degree than BHK or U20S cells (Figure 5). These data confirm 574 
that all the machinery necessary for HuNoV replication is conserved between 575 
human, hamster and mouse cells. Furthermore, reconstitution of the G3BP1 BV2 576 
microglial cells with WT G3BP1, at least partially restored the ability of the HuNoV GI 577 
replicon to form colonies, confirming the specificity of the effect. The presence of 578 
G3BP1 in the NV VPg-containing complexes again fits with our hypothesis that 579 
G3BP1 plays a role in promoting viral VPg-dependent protein synthesis. 580 
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We have previously found that norovirus infection leads to preferential viral-581 
translation whereby cellular mRNAs induced in response to norovirus infection are 582 
inefficiently translated (Emmott et al., 2017). This modification of host cell translation 583 
is at least partially driven by the ability of the viral NS6 protease to cleave PABP and 584 
the induction of apoptosis which results in cleavage of cellular translation initiation 585 
factors (Emmott et al., 2017). Importantly, whilst caspase cleaved translation 586 
initiation factors do not support host cell cap-dependent translation, we have 587 
previously found that the cleaved forms of eIF4G do support norovirus VPg-588 
dependent translation (Emmott et al., 2017).  The ability of the norovirus protease to 589 
cleave PABP and other substrates is also controlled by polyprotein processing and 590 
interactions with other viral proteins (Emmott et al., 2019). Recent work confirms that 591 
the preferential viral translation is not driven by the GCN2-mediated phosphorylation 592 
of eIF2 in MNV infected cells(Brocard et al., 2018). We note however that others 593 
have suggested that NS3 may contribute to the translational shut off seen in MNV 594 
infected cells (Fritzlar et al., 2019), with the caveat that this observation was made 595 
outside of the context of infected cells and used overexpressed tagged viral proteins.  596 
We suspect that noroviruses use multiple mechanisms that work co-operatively to 597 
enable the control of host gene expression and the subsequent translation of the 598 
cellular mRNAs. The relative contribution of these processes in any given cell type 599 
may also vary dependent on the degree to which the cells can sense and respond to 600 
viral infection through the induction of innate and apoptotic responses.  601 
The observation that many of the factors enriched using the VPg protein were only 602 
enriched on complexes purified with NS1/2 tagged infectious MNV, could suggest 603 
that the viral proteins present in the viral translation complex are distinct from those 604 
present in complexes active for viral RNA synthesis. However, we cannot formally 605 
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rule out other possible explanations including the possibility that the specific 606 
enrichment of translation factors on NS1/2 occurs because NS1/2 is the first protein 607 
to be translated from ORF1, therefore unprocessed NS1/2 at the N-terminus of the 608 
ORF1 polyprotein being actively translated could function as an anchor, facilitating 609 
the enrichment of ribosomes and the associated factors. In addition, we have 610 
previously seen that VPg-containing precursors may bind the translation initiation 611 
factor eIF4G less well (Leen et al., 2016), which could prevent some VPg (NS5) 612 
containing precursors associating with translation initiation complexes. Furthermore, 613 
the norovirus replication complex contains a number of highly conserved viral 614 
protein-viral protein interactions {Emmott:2019jp}. Within this network of interactions, 615 
the NS1/2 protein interacts with the viral RNA polymerase NS7, which in turn binds 616 
VPg. It is therefore possible that the interactions observed between the NS1/2 617 
proteins and the host proteins involved in translation, occurs via the formation of a 618 
NS1/2-NS7-VPg complex. How the viral protein-protein interactions within the 619 
replication complex integrate with the network of cellular proteins identified in the 620 
current study and how this facilitates viral replication and/or regulates the host 621 
response to infection, remains to be determined. 622 
This study provides an unprecedented insight into the identity of host factors likely 623 
involved in the norovirus life cycle. As detailed above, we focused our detailed 624 
analysis on the role of G3BP1 given that it was identified in all three screens, 625 
however it is likely that many of the host factors identified in each screen play key 626 
roles in the norovirus life cycle.  The high enrichment of proteins involved in vesicle-627 
mediated transport, organelle organization and exocytosis, fits well with our current 628 
understanding on the nature of the norovirus replication complex and the impact on 629 
host cell processes. Detailed analysis of the impact of norovirus non-structural 630 
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protein expression and MNV infection on host cell membrane architecture suggests 631 
that norovirus replication complexes are generated from the endoplasmic reticulum 632 
(ER), and results in the formation of single membrane vesicles (SMVs), double 633 
membrane vesicles (DMVs) and multi membrane vesicles (MMVs) 634 
{Doerflinger:2017fp}. The process by which the non-structural proteins induce the 635 
formation of these structures is unknown, but the NS1/2 and NS4 proteins are 636 
thought to be key to the process. We have previously reported that the NS1/2 protein 637 
from MNV and HuNoV interacts with the VapA and VapB proteins and that this 638 
interaction is required for efficient viral replication {McCune:2017ev}.  The norovirus 639 
NS4 protein associates with lipid droplets and is able to drive the formation of SMVs 640 
and DMVs {Doerflinger:2017fp}, suggesting that it may regulate the biosynthetic 641 
pathways involved in lipid synthesis or intracellular vesicular transport pathways. Our 642 
characterisation of the replication complex indicates an intimate link with numerous 643 
proteins involved in vesicle transport and lipid metabolism (Figure 2-figure 644 
supplement 1). Given that NS1/2 and NS4 interact to form a complex 645 
{Emmott:2019jp}, it is likely they work in concert to drive the formation of membrane-646 
bound replication complex by regulating the functions of multiple components, the 647 
characterisation of which will require further analysis. 648 
In conclusion, our data adds significantly to the growing body of literature on the role 649 
of G3BP proteins in the life cycle of viruses and further extends the functional roles 650 
of G3BP1 to include the promotion of viral translation processes. We identify G3BP1 651 
as a host protein that has a critical role in the life cycle of murine and human 652 
noroviruses, identifying the first cellular pro-viral protein with pan-norovirus activity. 653 
Furthermore, given the apparent importance of G3BP1 to an early stage of the 654 
 28 
norovirus life cycle, this work suggests that targeting G3BP1 may hold future 655 
therapeutic potential. 656 
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Figure Legends 680 
 681 
Figure 1. The norovirus VPg proteins interacts with ribosome associated 682 
translation initiation factors. A) Amino acid sequence alignment of the GV murine 683 
norovirus VPg sequences with VPg from representative human noroviruses from GI 684 
Norwalk virus (NV), GII,  and GIV. The position of the site of RNA linkage to the 685 
highly conserved tyrosine residue is highlighted in green. The eIF4G binding motif is 686 
boxed and the position of the C-terminal single amino acid change known to interfere 687 
with eIF4G binding highlighted in orange. B) m7-GTP sepharose was used to affinity 688 
purify eIF4F containing complexes from either wild-type BHK cells (BHK) or BHK 689 
cells containing the Norwalk virus (NV) replicon (BHK-NV). Samples of the lysate (L) 690 
or the affinity purified complexes (m7) were separated by SDS-PAGE then analysed 691 
by western blot for the indicate proteins. Molecular mass shown on the left of the 692 
gels represent the positions of molecular weight markers. C) GFP fusion proteins to 693 
either the wild type (WT) or C-terminal eIF4G binding domain mutants of the MNV 694 
and NV VPg proteins (F123A, F137A) were transfected into human 293T cells and 695 
subjected to immunoaffinity purification using anti-GFP. Samples of the input lysates 696 
(Input) and the purified complexes (GFP-IP) were then separated by SDS-PAGE and 697 
analysed by western blot analysis for the indicated proteins. Mock transfected cells 698 
served as a specificity control. The approximate expected molecular mass of each 699 
protein is shown to the left. D) Quantitative proteomics was used as described in the 700 
text to identify host factors that were affinity purified following transfection of GFP-701 
tagged derivative of either the NV or MNV VPg proteins. Proteins specifically 702 
enriched in comparison to the GFP control are shown. Data visualisation was 703 
performed using Cystoscape (Shannon et al., 2003) . E) Western blot analysis of cell 704 
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extracts (Input) or immunoprecipitated (GFP IP) complexes isolated from cells 705 
transfected as described in panel C. For clarity, the molecular masses shown in this 706 
panel refer to the expected mass of the protein being examined. 707 
 708 
Figure 1-Figure Supplement 1: Host factors binding to the norovirus VPg. 709 
Quantitative proteomics was used as described in the text to identify host factors that 710 
were affinity purified following transfection of GFP-tagged derivative of either the NV 711 
or MNV VPg proteins. Proteins specifically enriched on the murine norovirus or 712 
human norovirus (Norwalk) VPg proteins in comparison to the GFP control are 713 
shown in panels A and B respectively. Proteins that were identified as enriched in at 714 
least two of the three biological repeats were counted as potential binding proteins 715 
and the SILAC ratios were computed as the average of the two or three biological 716 
repeats. The raw values used to compute this figure are presented in Supplementary 717 
file 1. Panel C illustrates the proteins previously found to interact with the 5’ or 3’ 718 
termini of the MNV genome (Bailey et al., 2010; Vashist et al., 2012b) or to associate 719 
with MNV VPg using tandem affinity purification (Chung et al., 2014). Data 720 
visualisation was performed using Cystoscape (Shannon et al., 2003) 721 
 722 
Supplementary File 1: Raw data associated with figure 1. A) Log2 SILAC ratio of 723 
proteins identified in Norwalk virus (NV) VPg GFP Trap pull downs. The 724 
experimental details are provided in the materials and methods. SILAC ratios were 725 
computed by comparing the ratio of the peptides for each protein in the GFP control 726 
pull down to that obtained with the NV-GFP fusion protein. As described in the text 727 
each experiment was performed in three independent conditions varying the label in 728 
each biological sample. M/L – medium vs light sample, H/L – heavy vs light labelled 729 
 31 
sample and M/L – medium vs light sample. B) As described in panel A but as 730 
obtained using the MNV VPg-GFP fusion protein as the bait. 731 
 732 
Figure 2: Proteomic characterisation of the norovirus replication complex 733 
using infectious epitope tagged MNV. A) Schematic representation of NS1/2-734 
FLAG and NS4-FLAG viruses contain insertions of nucleotide sequences encoding 735 
the FLAG peptide DYKDDDDK (in yellow) in their coding sequences. The NS1/2-736 
FLAG virus FLAG peptide was inserted between 2 of the 3 caspase-3 cleavage sites 737 
present in NS1/2 (underlined).  B) BV2 cells labelled with stable derivatives of 738 
arginine and lysine were infected with either wild type MNV (WT) or recombinant 739 
epitope-tagged MNV as described in the materials and methods. 12 hours post 740 
infection samples were lysed, samples pooled and immunoaffinity purifications 741 
performed as described in the text. Samples of the cell lysates (Input) and the affinity 742 
purified complexes (IP:Flag) were analysed by SDS-PAGE on a 4-12% gradient gel 743 
prior to silver staining. The positions of the NS1/2, NS2 and NS4 proteins is shown. 744 
C) Western blot analysis of lysates purified from cells infected as described in panel 745 
B, for various viral proteins, confirming the specific enrichment of viral replicase 746 
components. D) Plot comparing the proteins identified in the complexes purified from 747 
cells infected with the NS1/2 and NS4 Flag expressing viruses. The raw data 748 
associated with this figure is presented in Supplementary file 2. Proteins identified in 749 
at least two of the three biological repeats are shown. SILAC ratios were calculated 750 
as an average of the two or three biological samples. All MNV proteins were 751 
identified in association with NS1/2 and NS4 (light blue) including the viral 752 
polymerase NS7, demonstrating enrichment of the MNV replication complex. 753 
Proteins previously identified as host factors potentially involved in some aspect of 754 
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the norovirus life cycle through various biochemical or genetic screens are shown in 755 
red. Selected highly enriched proteins are highlighted in black. The NS1/2 binding 756 
partner VapA (McCune et al., 2017) and paralog VapB were both enriched by NS1/2 757 
and NS4.  758 
 759 
Figure 2-Figure Supplement 1:  Additional analyses of NS1/2 and NS4-associated 760 
proteins. MNV proteins highlighted in light blue, and G3BP1 in gold. A) Gene 761 
ontology using PANTHER overrepresentation analysis of proteins copurifying with 762 
NS1/2 or NS4 (Log2 SILAC ratio >2 for either protein). Proteins in selected, mutually 763 
exclusive gene ontology categories are plotted in different colors as depicted .B) A 764 
number of factors previously identified as MNV host factors using proteomics or 765 
CRISPR approaches {Orchard:2019je, Chung:2014dd, Vashist:2012ke} copurified in 766 
pulldowns of NS1/2 and NS4 (highlighted red). C) Novel putative MNV host factors 767 
highly enriched (Log2 SILAC ratio >4 for either protein) by NS1/2 and NS4 are 768 
plotted in black. D) Proteins identified in pulldowns of NS1/2 and NS4 which were 769 
also identified in pulldowns of MNV VPg are plotted in red. E) Proteins enriched in 770 
pulldowns of NS1/2 and NS4 which were also identified using CRISPR screening as 771 
MNV host factors are plotted in red (positive host factors) and yellow (negative host 772 
factors), along with G3BP1 in gold. 773 
 774 
Figure 2-Figure Supplement 2: Further analysis of proteins enriched through MNV 775 
VPg proteomics and FLAG-tagged virus replication complex proteome data (Log2 776 
SILAC ratio >1). A) Venn diagram illustrating the degree of overlap between the 777 
proteins identified in the three proteomics approaches. The greatest overlap between 778 
VPg and the replication complex proteome data was observed between VPg and 779 
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NS1/2. G3BP1 was enriched in pulldowns of all three bait proteins (VPg, NS1/2 and 780 
NS4). B) The baits NS1/2 and NS4 both enriched VPg during replication complex 781 
pulldowns, but NS1/2 also enriched the VPg binding partner eIF4G, while NS4 did 782 
not. Immunoblot analysis revealed that NS4 enriched primarily the NS4/5 (VPg) 783 
polyprotein precursor, and not mature VPg, while NS1/2 enriched primarily the 784 
mature form of VPg (Figure 2C). C) Plot of all MNV VPg binding partners identified in 785 
Figure 1 which overlapped with proteins associated with the replication complex 786 
through NS1/2 and NS4 purification. Most VPg interaction partners were better 787 
enriched by NS1/2 than NS4, except G3BP1. D) Table showing Gene Ontology 788 
analysis of proteins enriched by VPg and NS1/2 during infection using PANTHER 789 
overrepresentation analysis, revealing a subset of the replication complex dedicated 790 
to translation and RNA metabolism.  791 
 792 
Supplementary File 2: Raw data associated with figure 2. A) Log2 SILAC ratio of 793 
proteins identified anti-FLAG immunoprecipitations from cells infected with the NS1/2 794 
tagged MNV. The experimental details are provided in the materials and methods. 795 
SILAC ratios were computed by comparing the ratio of the peptides for each protein 796 
in the anti-Flag immunoprecipitations performed on cells infected with wild type 797 
MNV. As described in the text each experiment was performed in three independent 798 
conditions varying the label in each biological sample. M/L – medium vs light sample, 799 
H/L – heavy vs light labelled sample and M/L – medium vs light sample. The Log2 800 
transformed values and the average values are shown. B) As described in panel A 801 
but as obtained using the NS4-FLAG tagged MNV. C) Combined dataset obtained 802 
using NS1/2 and NS4 tagged viruses showing the average Log2 SILAC ratios. 803 
 804 
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Supplementary file 3: Gene ontology and cross comparison analysis of the 805 
data obtained in Figure 2. A). Gene ontology of the host proteins found to be 806 
enriched by both NS1/2 and NS4. B) PANTHER overexpression analysis of host 807 
proteins found to be enriched by both NS1/2 and NS4. C) Raw data used for 808 
PANTHER analysis shown in panel B. D) Colour code for data shown in panel C. E) 809 
List of host proteins identified in previous studies as having (potential) roles in the 810 
norovirus life cycle along with their degree of overlap with the host proteins identified 811 
using NS1/2 and NS4. F) Gene ontology analysis of host proteins identified as 812 
binding to the MNV NS1/2 protein and enriched using GFP-tagged MNV VPg. 813 
 814 
Figure 3: CRISPR screen identifies host genes positively and negatively 815 
selected upon MNV infection. A) Schematic overview of the infection CRISPR 816 
screen workflow. BV2 cells expressing Cas9 were transduced with a CRISPR library 817 
then subsequently infected with either MNV CR6 or CW3 for 24 hours. Cells 818 
remaining after 24 hours were harvested and used for guide RNA abundance 819 
analysis as described in the text. B) Volcano plot identifying candidate genes 820 
enriched upon MNV-CW3 (red) or MNV-CR6 (blue); red or blue labelled genes 821 
correspond to the top-ten positive or negatively selected genes ranked by the 822 
STARS algorithm. C) Plot comparing the Log2 fold change in guide RNA abundance 823 
in the CRISPR library transduced BV2 cells following infection with either CR6 or 824 
CW3 MNV. 825 
 826 
Supplementary File 4. Raw data and further analysis of the data obtained in 827 
figure 3. A) List of genes ranked with a positive STARS obtained with the Brie 828 
CRISPR screen against MNV CW3. B) List of genes ranked with a negative STARS 829 
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obtained with the Brie CRISPR screen against MNV CW3. C) As in panel A except 830 
using the MNV strain CR6. D) As in panel B except using the MNV strain CR6. E) 831 
Combined STARS ranking for the genes in both MNV CW3 and CR6 data sets. F) 832 
Comparison of genes with positive and negative STARS values in the data sets 833 
obtained using MNV CW3 and CR6. G) Comparison of data from panel A and C with 834 
the previous MNV CRISPR screens. H) Gene ontology overexpression analysis of 835 
genes identified in this study as having positive STARS values for both MNV CW3 836 
and CR6. 837 
 838 
Supplementary File 5. Comparison of data obtained from three screens to 839 
identify host factors involved in the norovirus life cycle. A) Comparison of the 840 
data obtained using MNV VPg-GFP trap with the MNV NS1/2 and NS4-FLAG tagged 841 
purifications. B) Comparison of the data obtained using the CRISPR screen and the 842 
MNV NS1/2 and NS4-FLAG tagged purifications. C) Comparison of the data 843 
obtained from all three screens. 844 
 845 
Figure 4: CRISPR knockout of G3BP1 renders cells non permissive for MNV  846 
replication. A) Western blot analysis of three independent G3BP1 clones for 847 
GAPDH, G3BP1 and G3BP2.  B) High multiplicity, single cycle growth curve analysis 848 
of the impact of G3BP1 ablation on MNV  replication. BV2 G3BP1 clone C cells 849 
were infected at a MOI of 10 TCID50/cell, samples were collected at the time points 850 
illustrated, the samples then processed and titrated by TCID50 as described in the 851 
text. The error bars represent standard errors of three biological repeats and the 852 
data are representative of at least three independent experiments. C) Wild type (WT) 853 
or G3BP1 clone C BV2 cells were plated in a 96 well plate and subsequently 854 
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infected using a serial dilution of either EMCV or MNV. Cells were fixed in 855 
paraformaldehyde and stained with crystal violet 5 days post infection. D) Light 856 
micrographs of WT or G3BP1 cells either mock infected (-) or infected with EMCV 857 
or MNV and visualised 5 days post infection.  858 
 859 
Figure 5. G3BP1 is required for human Norwalk virus replication in cell culture. 860 
A) Colony formation ability of human norovirus VPg-linked RNA isolated from BHK-861 
NV replicon containing cells is dependent on the presence of VPg. NV VPg-linked 862 
RNA isolated from BHK-NV cells was either mock treated or treated with proteinase 863 
K prior to transfection into BHK cells. Wells were transfected with either 1.5g or 864 
0.75g of total RNA isolated from NV replicon containing BHK cells. Following 2 865 
weeks of antibiotic selection with G418, surviving replicon containing colonies were 866 
fixed and stained with crystal violet in paraformaldehyde. B) NV replicon colony 867 
forming assay in WT and G3BP1-/- U2OS cells performed as described in panel A, 868 
with the exception that colonies were stained 12 days post transfection. C) 869 
Quantification of NV replication in WT or G3BP1 U2OS cells following transfection 870 
of viral VPg-linked RNA. Viral RNA was quantified by RT-qPCR following 871 
transfection and antibiotic selection. The error bars represent the standard error of 872 
three biological repeats and are representative of three independent experiments. D. 873 
Analysis of the impact of loss of G3BP1 on NV replication in BV2 cells. Wild type 874 
BV2 cells, G3BP1 BV2 cells or G3BP1 BV2 cells reconstituted with wild type full 875 
length G3BP1 were transfected with NV replicon VPg-linked RNA. Following 876 
selection with G418 for 3 weeks, the cells were fixed and stained with toluidine blue 877 
to facilitate the visualization of microcolonies. Pictures of the entire well and three 878 
independent fields of view are shown. 879 
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 880 
Figure 6: MNV replication in BV2 cells requires the RNA binding activity of 881 
G3BP1. A) Schematic illustration of the G3BP1 truncations used to identify the 882 
domains involved in the norovirus life cycle. The positions of the various domains 883 
including the RRM and RGG domains deleted in the RGG and RGG/RRM 884 
mutants are also shown. Western blot analysis of wild type BV2 cells (WT) or a 885 
G3BP1 cells (clone 1B2) and the respective complemented lines expressing either 886 
WT or the various G3BP1 truncations. Cells were lysed prior to separation by 12% 887 
SDS-PAGE. B) WT or G3BP1 cells complemented with the indicated constructs 888 
were plated in a 96 well plate then infected with a serial dilution of MNV, before 889 
being fixed and stained 5 days post infection as described in the text. C) WT or 890 
G3BP1 cells complemented with the indicated constructs were infected with MNV 891 
at an MOI of 10 TCID50 per cell. After 24 hours the virus yield was determined by 892 
TCID50. The error bars represent the standard error of three independent repeats. 893 
The data are representative of at least two independently repeated experiments.  894 
 895 
Figure 7: Loss of G3BP1 results in a defect following transfection of viral VPg-896 
linked RNA into G3BP1 cells.  A) The indicated cell lines were transfected with 897 
MNV viral RNA and harvested at 9 hours post transfection for TCID50 to assess the 898 
virus yield. In some instances, the nucleoside analogue 2CMC was included to 899 
inhibit viral replication. The dotted line indicates the limit of detection (LOD) and the 900 
error bars represent the standard error from three biological repeats. B) Infectious 901 
virus yield from G3BP1 and reconstituted cell lines performed as described in panel 902 
A.  C) and D) illustrate the accompanying western blots for samples prepared in 903 
panel A and B respectively. Samples were prepared at 24 hours post transfection, 904 
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prior to harvesting, separation by SDS-PAGE on a 4-12% gradient gel prior to 905 
western blotting for the indicated proteins. 906 
 907 
Figure 8: The Lack of G3BP1 results in a failure to produce viral negative 908 
sense RNA.  The experimental design is illustrated in A. Wild type or G3BP1 (1B2) 909 
cells were infected prior to the addition of the nucleoside analogue 2CMC to prevent 910 
viral RNA synthesis. Samples were harvest at the indicated time post infection and 911 
viral positive (B) and negative sense RNA quantified by stand specific RT-qPCR (C). 912 
Error bars represent standard error of three biological repeats. LOD refers to the limit 913 
of detection of the assay. D) and E) Viral RNA synthesis following transfection of 914 
viral VPg-linked RNA into WT or two G3BP1 cell lines. F) and G) Viral RNA 915 
synthesis following transfection of viral VPg-linked RNA into G3BP1 (1B2) 916 
complemented with full length G3BP1 or truncated derivatives. Error bars represent 917 
standard error of three biological repeats. 918 
 919 
Figure 9: G3BP1 is required for the association of VPg and norovirus VPg-920 
linked RNA with ribosomal subunits. A) GFP-Trap immunoprecipitation of 921 
complexes isolated on with GFP alone or GFP tagged wild type MNV-VPg 922 
demonstrating the pull down of eIF4G1, G3BP1 and 40S subunits (RpS6). BV2 cells 923 
were transfected with the relevant constructs, lysates prepared and GFP-Trap pull 924 
downs performed as detailed in the text. Samples were separated by SDS-PAGE 925 
and western blotted for the proteins as shown. B) Mutations in the eIF4G binding 926 
domain ablate the association of VPg with G3BP1 and ribosomal subunits and the 927 
reconstitution of G3BP1 expression in G3BP1 BV2 cells restores the interaction. 928 
GFP-Trap pull downs were performed as described in panel A with the addition of 929 
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the MNV VPg F123A mutation known to reduce the association with eIF4G and the 930 
inclusion of the in G3BP1 1B2 cell line engineered to express a Flag-tagged 931 
derivative of G3BP1. Following the pull down samples were analysed by western blot 932 
for presence of the ribosomal subunits using RpS6 and RpL4 as markers for the 933 
small and large ribosomal subunits respectively.  > denoted the RpL4 proteins 934 
whereas * indicated the presence of GFP-VPg fusion proteins, present on the same 935 
membrane due to the sequential probing of the membrane. C) Loss of G3BP1 936 
results in decreased association between norovirus RNA and ribosomal proteins. WT 937 
or cells lacking G3BP1 were infected with MNV in the presence of the RNA 938 
polymerase inhibitor 2CMC and the amount of viral RNA found associated with RpS3 939 
determined by RNA-IP. Error bars represent SEM of duplicate samples and the 940 
values are expressed as fold enrichment with respect to the IgG control antibody. 941 
 942 
Figure 9-Figure Supplement 1. G3BP1 is required for the association of VPg 943 
with ribosomal subunits. GFP-Trap pull down was performed as described in 944 
figure 9 following transfection of GFP tagged derivatives of either a WT or a F123 945 
MNV VPg proteins into WT BV2 cells, G3BP1 BV2 cells or G3BP1 BV2 cells 946 
engineered to express Flag tagged derivative of WT G3BP1. Following the GFP-947 
Trap pull down, samples of the input and purified complexes were analysed by 948 
western blot for the proteins as shown.  949 
 950 
Figure 10: G3BP1 is required for polysome association of viral RNA 951 
association. A) Polysome profiles of the ribosome containing fractions from mock or 952 
MNV infected wild type (WT) or G3BP1 (1B2) BV2 cells at 4 and 9 hours post 953 
infection (moi 3 TCID50/cell). B) Relative viral RNA levels present in ribosome 954 
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containing fractions expressed relative to WT infected BV2 cells. C) Extended 955 
gradient fractionation of WT or G3BP1 cells infected with MNV and harvested 9 956 
hours post infection. Viral RNA levels across the gradient are expressed as 957 
described in panel B. Error bars represent standard error of three technical repeats 958 
from each biological samples, defined as a single fraction from a single experiment. 959 
The data shown in panels A-C are representative of at least three experimental 960 
repeats. 961 
 962 
Figure 11: G3BP1 is required for efficient norovirus VPg-dependent 963 
translation. 964 
A) Illustration of the bicistronic construct used to assess the in vitro translation 965 
efficiency of the extracts prepared from WT BV2 cells or cells lacking G3BP1. The 966 
location of the 5’ cap and the 3’ poly (A) tails are highlighted in relation to the renilla 967 
and firefly luciferase coding regions, along with with the CrPV IRES. Comparsion os 968 
cap (B) and CrPV-IRES dependent translation (C) in translation competent extracts 969 
prepared from WT BV2 cells or BV2 cells lacking G3BP1. Extracts were 970 
programmed with in vitro transcribed RNA as described in the text and the levels of 971 
luciferase compared to those obtained using rabbit reticulocyte lysate (RRL). D) 972 
Translation of MNV VPg-linked viral RNA is diminished in nuclease treated extracts 973 
prepared from G3BP1 cells. Translation of viral RNA in rabbit reticulocyte lysates 974 
(RRL) was used as a side by side comparison. The positions of the viral proteins 975 
quantified by phosphor imaging are indicated with arrow heads (1-5). E) 976 
Quantification of norovirus protein synthesis for each of the identified protein 977 
products in panel D and total translation levels across multiple experiments. The 978 
levels of viral translation is expressed as a percentage relative to the same protein 979 
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product translated in extracts prepared from WT cells. The error bars represent the 980 
standard error of three independent experiments. F) Norovirus VPg-dependent 981 
translation in non-nuclease treated extracts prepared from WT or G3BP1 cells. The 982 
total translation efficiency for the viral proteins, highlighted by arrowheads, is shown 983 
below the respective lane. Translation efficiency is expressed as a percentage in 984 
comparison to the average of translation seen in extracts prepared from WT cells 985 
across all biological repeats.  E) Quantification of viral proteins produced in panel (D) 986 
plotted as % translation efficiency with respect to the translation levels observed in 987 
non-nuclease treated extracts from WT BV2 cells.. 988 
 989 
Figure 11-Figure Supplement 1: A) Characterisation of viral VPg-linked RNA. The 990 
sensitivity of purified MNV VPg-linked RNA to various nucleases was compared to in 991 
vitro transcribed capped MNV gRNA (cap-gRNA) and the MNV1 full length cDNA 992 
construct. RppH was included as a decapping enzyme require for Xrn1-mediated 993 
cleavage of capped RNAs. Following digestion, the samples were analysed on a 1% 994 
native agarose gel. B) In vitro translation of viral VPg linked RNA in rabbit 995 
reticulocyte lysates demonstrated robust translation and the production of a protein 996 
profile indistinguishable from in vitro transcribed capped genomic RNA (cap-g). 997 
Capped sub-genomic (cap-sg) RNA was included to demonstrate the location of the 998 
VP1 and VP2 proteins. C) The translation of MNV VPg-linked RNA in extracts 999 
prepared from G3BP1 cells is reduced across multiple time points. In vitro 1000 
translations prepared in rabbit reticulocyte lysates (RRL) using in vitro transcribed 1001 
capped genomic RNA (cap-g) or capped sub-genomic (cap-sg), along with viral VPg-1002 
linked RNA, was used as a reference for the expected mass of the viral proteins. 1003 
 1004 
  1005 
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Materials and methods. 1006 
Cells. The murine microglial BV2 cell line  (Blasi et al., 1990) was provided by 1007 
Jennifer Pocock (University College London). BV2 cells were maintained in DMEM 1008 
supplemented with 10% FCS (Biosera), 2 mM L-glutamine, 0.075 % sodium 1009 
bicarbonate (Gibco) and the antibiotics penicillin and streptomycin. BHK cells 1010 
engineered to express T7 RNA polymerase (BSR-T7 cells, obtained from Karl-Klaus 1011 
Conzelmann, Ludwid Maximillians University, Munich, Germany) were maintained in 1012 
DMEM containing 10 % FCS, penicillin (100 SI units/ml) and streptomycin (100 1013 
μg/ml), and 0.5 mg/ml G418. U2OS cells and derivatives of them were obtained from 1014 
Nancy Kedersha (Harvard Medical School).  All cell lines were screened for 1015 
mycoplasma and confirmed as negative. The identity of the cell lines was not 1016 
confirmed by STR profiling. 1017 
 1018 
Generation of G3BP1 KO cells. BV2 cells were cultured in DMEM containing 10% 1019 
FBS and 1% HEPES. G3BP1 knockout BV2 cells were generated using two 1020 
approaches. The clone 1B2 was generated by transiently transfected with Cas9 and 1021 
a sgRNA (5TTCCCCGGCCCCGGCTGATGNGG) targeting exon 7 of G3BP1.  BV2 1022 
cells were then single cell cloned and G3BP1 was sequenced by Illumina HiSeq. 1023 
BV2 cells are polyploid at the G3BP1 locus as described previously (Orchard et al., 1024 
2016). Clone 1B2 also had three independent deletions at the sgRNA binding site 1025 
resulting in deletions of 1, 2, and 5 base pairs respectively. The mutations introduced 1026 
into the IB2 BV2 cell clone resulted in frame shifts at nucleotide positions 253, 254 1027 
and 244 and the absence of detectable G3BP1 protein as measured by western blot. 1028 
G3BP1 knockout BV2 cell clones A, C and F were generated using an independent 1029 
approach that relied on first generating a pool of three lentiviruses carrying guide 1030 
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RNAs TGTGCAACATGTCCGGGGCC, CAAACTCCCGCCCGACCAGC and 1031 
TAGTCCCCTGCTGGTCGGGC targeting the first 100bp of the coding sequence, 1032 
cloned into pLentiCRISPRv2 (Sanjana et al., 2014). BV2 cells were then transduced 1033 
with the pool of 3 lentiviruses, selected by puromycin treatment for 72 hours, prior to 1034 
cloning by limiting dilution. Individual clones were then screened by western blot for 1035 
the absence of G3BP1. 1036 
 1037 
G3BP1 complementation. Mouse G3BP1 cDNAs were subcloned into pCDH-MCS-1038 
T2A-puro-MSCV lentiviral vector (System Biosciences) by NEBuilder HiFi DNA 1039 
assembly (New England Biolabs). Mouse G3BP1 was subcloned from pCM6-G3BP1 1040 
(MR207441; Origene). Mouse G3BP1 lentiviral constructs deficient in the C-terminal 1041 
RGG domain (mG3BP1ΔRGG) and the RGG and RRM domains 1042 
(mG3BP1ΔRGGRRM) were generated by Gibson cloning from the pCMV6-G3BP1 1043 
vector. Lentivirus was generated by co-transfecting pCDH-G3BP1-T2A-puro-MSCV 1044 
with pCMV-VSV-G and pSPAX2 into 293T cells with Trans-IT LT1 (Mirus 1045 
Biosciences) per manufacture instructions. Two days post-transfection, supernatants 1046 
were harvested, filtered through a 0.22 micron filter, and stored at -80C.  Lentivirus 1047 
encoding G3BP1 or an empty control was then used to transduce G3BP1 KO 1B2 1048 
BV2 cells.  Two days post-transduction BV2 cells were selected with puromycin 1049 
(2.5ug/ml) for six days.   1050 
 1051 
MNV growth curves 1052 
To determine the effects of G3BP1 disruption on MNV replication G3BP1 WT, KO, or 1053 
complemented cells were plated in each well of a flat bottom 96-well plate and then 1054 
infected with either MNV strains CW1, CW3, or CR6 as described in the text. 1055 
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Infected cells were flash frozen at -80°C at the times post infection indicated in the 1056 
text. Viral replication was then assessed by plaque assay or TCID50 in BV2 cells as 1057 
described in the text. In cases where the appearance of virus-induced cytopathic 1058 
effect was examined, infected monolayers were either visualized by light microscopy 1059 
directly or fixed with crystal violet in formalin, prior to washing and imaging.  1060 
 1061 
CRISPR screens. The CRISPR screen was performed similarly to that described 1062 
previously (Orchard et al., 2016) with a number of modifications that included the use 1063 
of the Brie gRNA library to reduce off target effects (Doench et al., 2016) and shorter 1064 
infection times to improve the recovery of gRNAs that may also compromise cell 1065 
viability. BV2 cells stably expressing Cas9 nuclease (Orchard et al., 2016) were 1066 
transduced with the Brie library using previously described protocols (Doench et al., 1067 
2016). MNV strains CW3 and CR6 were used to infect BV2 CRISPR library at MOI 5 1068 
pfu/cell and cells were isolated  24 hours post infection and preparation of gDNA for 1069 
sequencing as described previously (Orchard et al., 2016).  The screen relies on the 1070 
premise that guide RNAs targeting genes that are overrepresented following 1071 
infection represent genes that when disrupted are protected against infection and 1072 
therefore likely represent factors with pro-viral activity. Likewise, genes for which 1073 
guide RNA are underrepresented suggest that infection had proceeded faster and 1074 
the gene is anti-viral. Following sequencing, the data was analyzed by STARS 1075 
method as previously described (Doench et al., 2016; Orchard et al., 2016). 1076 
Visualization of candidate genes was accomplished using R (RStudio, Inc., Boston, 1077 
MA).  1078 
 1079 
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Maintenance of SILAC cell lines. Stable isotope labelling of amino acids in cell 1080 
culture  of BV2 cells (SILAC, Ong et al., 2002), was carried out in high-glucose 1081 
DMEM lacking arginine and lysine (Sigma-Aldrich), supplemented with dialyzed  fetal 1082 
bovine serum, 1% L-glutamine, 1X nonessential amino acids, 10 mM HEPES, and 1083 
1X penicillin/streptomycin. SILAC media were supplemented with Light (R0K0), 1084 
Medium (R6K4) or Heavy (R10K8) Arginine and Lysine (Cambridge Isotope 1085 
Laboratories). BV2 cells were maintained in SILAC medium for 2 weeks to ensure 1086 
complete metabolic labelling of proteins. Labelling of HEK-293T cells was performed 1087 
essentially as described for BV2 cells, with the omission of 10 mM HEPES and 1X 1088 
non-essential amino acids from the cell culture media. 1089 
 1090 
DNA based recovery of murine norovirus. Experiments were performed according 1091 
to previously published protocols (Chaudhry et al., 2007). Briefly, BSRT7 cells were 1092 
infected to an MOI of 0.5-1 PFU/cell with fowlpox virus expressing T7 RNA 1093 
polymerase. Cells were then transfected with a plasmid encoding the MNV full length 1094 
clone, or a derivative thereof (e.g. pT7 MNV 383FLAG 3’Rz or pT7 MNV 2600FLAG 1095 
3’Rz, our FLAG-tagged virus constructs containing FLAG tags in either NS1/2 or 1096 
NS4 respectively). MNV was harvested by freeze-thaw at 24h post-transfection. 1097 
 1098 
To generate higher titre stocks, WT MNV, NS1/2-FLAG MNV, and NS4-FLAG MNV 1099 
(Thorne et al., 2012) generated using the DNA based recovery method described 1100 
above were passaged once in BV2 cells. After 80-90% of cells displayed visible 1101 
cytopathic effects (CPE) of viral infection, flasks containing infected cells were frozen 1102 
at -80oC. Flasks were frozen and thawed twice before cell debris was removed by 1103 
centrifugation at 4000 rpm for 10 minutes in a benchtop centrifuge. Viruses were 1104 
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pelleted by centrifuging over a 30% sucrose cushion at 76,755xg in a SW32ti rotor 1105 
for 2 hours at 4oC. Virus pellets were resuspended overnight in PBS to achieve 100-1106 
fold concentration. Concentrated virus was then passed through a 23-gauge blunt 1107 
needle 15 times, and clarified by centrifugation at maximum speed in a benchtop 1108 
microcentrifuge for 10 minutes. Supernatant aliquoted, and titrated prior to use.  1109 
 1110 
Infection of SILAC labelled BV2 cells with FLAG-tagged viruses. SILAC-labelled 1111 
BV2 cells were infected with WT MNV, NS1/2-FLAG or NS4-FLAG viruses at an MOI 1112 
of 10 TCID50 cell. Infections were performed in triplicate, using different 1113 
combinations of SILAC-labeled BV2 cells each time to control for any impact of the 1114 
SILAC labelling.  Infected cells were then plated in the appropriate SILAC media. At 1115 
10 hours post-infection, cells were harvested by scraping, and pelleted at 500xg for 5 1116 
minutes. Cells were then washed 3 times with ice-cold PBS, and were lysed in (0.5% 1117 
Nonidet-P40 substitute, 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 2 mM 1118 
MgCl). Benzonase nuclease (Sigma-Aldrich) was added to lysis buffer to a 1119 
concentration of 5 l/ml to prevent nonspecific interactions mediated by RNA or 1120 
DNA. 1121 
 1122 
Transfection of SILAC labelled HEK-293T cells with GFP-tagged VPg. SILAC-1123 
labelled HEK-293T cells were transfected with pEGFP-C1 (control) or derivatives 1124 
thereof containing either human or murine norovirus VPg protein as described in 1125 
Emmott & Goodfellow, (2014). GFP fusions of both wild-type protein or mutant VPg 1126 
containing a mutation to inhibit initiation factor binding (MNV: F123A, HuNoV: 1127 
F137A) were used. Cells were transfected using Lipofectamine 2000 (Life 1128 
Technologies) according to the manufacturers protocol, using antibiotic-free SILAC 1129 
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media in place of Opti-mem. The experiment was performed in triplicate and SILAC 1130 
labels switched in one of the replicates. 1131 
 1132 
FLAG and GFP-TRAP immunoprecipitation. FLAG immunoprecipitations were 1133 
performed following the manufacturer’s protocol (FLAG M2 beads, Sigma Aldrich) as 1134 
described (Thorne et al., 2012). In brief, protein concentration in lysates was 1135 
normalized using BCA. Lysates were then diluted with 1 volume of wash buffer (10 1136 
mM Tris-Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA). Equal volumes of anti-FLAG 1137 
affinity gel were dispensed into either WT infected cell lysates, or lysates of cells 1138 
infected with NS1/2-FLAG or NS4-FLAG. Binding was carried out overnight at 4oC 1139 
with rotation. After binding, beads were washed 3 times with wash buffer. All liquid 1140 
was carefully removed from each tube, before boiling in SDS-PAGE loading buffer 1141 
for 10 minutes. GFP-trap immunoprecipitation of GFP-tagged VPg was 1142 
accomplished using GFP-trap beads (Chromotek) per the manufacturer’s protocol, 1143 
as described (Emmott and Goodfellow, 2014). RNase cocktail (Ambion) was also 1144 
included in the lysis buffer at a concentration of 5 l/ml to prevent non-specific 1145 
interactions mediated by RNA. In all cases, light, medium, and heavy-labelled 1146 
proteins eluted from the beads for each experimental replicate were pooled together 1147 
in a ratio of 1:1:1 before submission for mass spectrometry analysis at the University 1148 
of Bristol Proteomics Facility. 1149 
 1150 
Mass spectrometry analysis. Mass spectrometry analysis was performed at the 1151 
University of Bristol Proteomics Facility. In brief, samples were run into precast SDS-1152 
PAGE gels for 5 minutes, the entire sample cut from the gel as a single band, and 1153 
then subjected to in-gel tryptic digestion including reduction and alkylation using a 1154 
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ProGest automated digestion unit. The resulting peptides were fractionated using a 1155 
Dionex Ultimate 3000 nanoHPLC system in line with an LTQ-Orbitrap Velos or 1156 
Orbitrap Tribrid Fusion mass spectrometer.  1157 
 1158 
Interpretation of SILAC Proteomics data. Raw data files were processed and 1159 
quantified using Maxquant v1.5.5.1 or 1.6.0.16 (Tyanova et. al. 2016). The GFP-VPg 1160 
experiments were searched against the Uniprot human database (70,550 entries, 1161 
downloaded September 19th 2016) plus a custom FASTA file containing the wild-type 1162 
and mutant VPg sequences. The raw data, search results and FASTA files can be 1163 
found as part of PRIDE submission PXD007585 (Reviewer username: 1164 
reviewer75984@ebi.ac.uk, Password: BH2pTctW). The FLAG-virus experiments 1165 
were searched against the Uniprot mouse database (Swiss-prot only, 16,966 entries, 1166 
downloaded May 19th 2018) plus a custom FASTA file containing the various Murine 1167 
norovirus proteins. The raw data, search results and FASTA files can be found as 1168 
part of PRIDE submission PXD011779 (Reviewer username: 1169 
reviewer49419@ebi.ac.uk, Password: eLYwivNP). Data were searched with default 1170 
Maxquant parameters including upto 2 missed tryptic cleavages, oxidation of 1171 
methionine and N-terminal acetylation as variable modifications, and 1172 
carbamidomethylation of cysteine as a fixed modification. The data were searched 1173 
against a reverse database and PSM and Protein FDR were set to 0.01. The 1174 
requantify option was not selected.  1175 
 1176 
GFP-VPg data were analysed as described previously (Emmott and Goodfellow, 1177 
2014). FLAG-virus experiments were analysed by computing the pairwise ratios of 1178 
samples infected with NS1/2-FLAG or NS4-FLAG relative to WT MNV-infected 1179 
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controls. Log2 SILAC ratios for proteins identified in at least 2/3 replicates were 1180 
averaged, and ratios for NS1/2-FLAG:WT and NS4-FLAG:WT were plotted for 1181 
comparison of host cell proteins by viral replication complex-associated proteins.  1182 
 1183 
Assessment of virus-induced cytopathic effect. BV2 WT, KO G3BP1 or 1184 
respective G3BP1 complemented cells as described in the text, were seeded onto 1185 
96 well plates and infected with serial 10-fold dilutions (starting at MOI=10 1186 
TCID50/cell) of MNV (CW1) or EMCV. At 48h post-infection, cells were fixed in ice-1187 
cold methanol and stained with toluidine blue prior to washing and imaging. 1188 
 1189 
Cap-Sepharose purification for eIF4F complex. Cell lysates were prepared from 1190 
BHK parental cells or BHK containing GI Norwalk virus (BHK-NV) replicon cells in 1191 
cap-Sepharose lysis buffer (100 mM KCl, 0.1 mM EDTA, 10% glycerol, 2 mM MgCl2, 1192 
20 mM HEPES, pH 7.6 in KOH) with 1% TX-100, proteinase and phosphatase 1193 
inhibitor cocktails (Calbiochem). Cytoplasmic extracts were centrifuged and RNase 1194 
treated for 15 min at room temperature.  At least 1000 µg of the cell lysates were 1195 
incubated with Sepharose beads coupled to 7-methylguanosine (m7GTP, Jena 1196 
Biosciences). Input cell lysates were collected for western blot analysis while the 1197 
remaining were incubated overnight with continuous rotation at 4°C. The eIF4F-1198 
enriched complex was precipitated and washed 2 times with cap-sepharose lysis 1199 
buffer. Bound proteins were eluted in 2x reducing SDS-PAGE samples buffer and 1200 
resolved by SDS-PAGE prior to western blot. 1201 
 1202 
Human Norwalk virus colony formation assay. Total RNAs extracts from BHK or 1203 
BHK-NV replicon-containing cells (Kitano et al., 2018) were pretreated with and 1204 
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without proteinase K (10 µg/ml) in 10 mM Tris, pH 8.0, 1.0 mM EDTA, 0.1 M NaCl, 1205 
and 0.5% SDS. Pretreated RNAs were immediately purified using GenElute RNA 1206 
purification columns (Sigma).  Serial 10-fold dilutions of mock or proteinase K-treated 1207 
RNAs were transfected in BHK cells and 24 h post transfection, cells were passaged 1208 
and maintained in growth media containing 0.5 mg/ml G418. Colonies began to form 1209 
after 5 d and were allowed to grow until 14 d.  All plates were harvested at day 14 1210 
and well-formed colonies were fixed in 10% formaldehyde and stained with toluidine 1211 
blue. A similar protocol was followed to assess colony formation in U2OS cells with 1212 
the exception that selections were maintained for up to 12 days post transfection. 1213 
Where indicated, cell aliquots from each time point were collected for qRT-PCR 1214 
analysis to assess viral RNA synthesis over time.  1215 
 1216 
RNA co-immunoprecipitation. Coimmunoprecipitation of viral RNA with RpS3 and 1217 
IgG, as irrelevant control, was performed using BV2 WT and BV2ΔG3BP1 clone IB2 1218 
cells inoculated with MNV1 at MOI of 50 TCID50 per cell in the presence of 400μM 1219 
2-CMC. Cell lysates equilibrated in EE buffer (50 mM HEPES, pH 7.0, 150 mM NaCl, 1220 
0.5% NP-40, 10% glycerol, 2.5 mM EGTA, 5 mM EDTA, 1 mM DTT, 100 ug/mL 1221 
Heparin, and HALT protease and phosphatase inhibitor cocktail) as previously 1222 
described were pre-incubated with antibody against either RpS3 or IgG for 12 h at 1223 
4°C with continuous rotation. Protein A/G Ultralink resin slurry (Thermo Fisher 1224 
Scientific) was then added into cell lysates and antibody mixture and incubated 1225 
further for 12 h at 4°C. Resin were washed with EE buffer 3x and the complex bound 1226 
to the resin were eluted in 0.1M glycine, pH 2. Elutions were subjected to RNA 1227 
extraction and bound viral RNA were quantitated by RT-qPCR.  1228 
 1229 
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Polyribosome fractionation analysis. BV2 WT and BV2 ∆G3BP1 cells were 1230 
seeded at a density of 7.5 x 106 cells per T-75 flask, and then either mock infected or 1231 
infected with MNV1 (CW1) at MOI 3 TCID50 per cell in the presence of 2-CMC 1232 
(400µM) for each set of infection. After 1h, the inoculum was then removed; the cells 1233 
were washed and maintained in growth media containing 2-CMC accordingly until 1234 
the cells were harvested at 4h and 9h p.i. Prior to harvesting, cells were treated with 1235 
cycloheximide (CHX) for 10 mins at 37°C (Sigma-Aldrich; 100 µg/ml) and were 1236 
rinsed with 5 ml of ice-cold PBS supplemented with CHX 100 µg/ml. Polysome lysis 1237 
buffer [20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5mM MgCl, 1 mM DTT, 1% Triton X-1238 
100, 100 µg/ml cycloheximide, 25 U/ml TURBO DNase (Life Technologies)] was 1239 
used to lyse the cells. Lysates were clarified by centrifugation for 20 min at 13,000 g 1240 
at 4°C. Aliquots of the lysates were collected for BSA assay and qPCR analysis 1241 
against MNV1 RNA before proceeding with fractionation. Input lysates were 1242 
normalized to total protein concentration and RT-qPCR was used to confirm the 1243 
levels of viral RNA in samples were comparable. Lysates were subjected next to 10-1244 
50% sucrose gradient centrifugation for 90 mins SW41Ti rotor at 190,000 x g at 4°C. 1245 
The gradients were fractionated at 0.5 ml/min and the levels of RNA in each sample 1246 
measured using an in line-254 nm spectrophotometer connected to a chart recorder. 1247 
RNAs were extracted from each fraction, converted to cDNA and immediately used 1248 
for qPCR. The distribution of viral RNA across the gradient was then calculated as 1249 
percentage (%) of the viral RNA seen in WT BV2 cells using the reference gene 1250 
(GAPDH) to obtain normalized values across the gradient.  Samples were performed 1251 
in duplicates on the same qPCR plate, and the observations were robust across 1252 
three independent experiments. Data were collected using a ViiA 7 Real-Time PCR 1253 
System (Applied Biosystems). 1254 
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 1255 
Transfection of VPg-linked MNV RNA into BV2 cells. VPg-linked RNA purified 1256 
from MNV-1 virus particles was transfected in BV2 cells using NEON™ as previously 1257 
described  (Yunus et al., 2010). Total cell lysates were harvested at 3 and 9 hours 1258 
post transfection with RIPA buffer. 10μg total lysates were analysed by 4-12% SDS-1259 
PAGE (Invitrogen) and antibodies against MNV, VPg, G3BP1 and GAPDH were 1260 
used for detection using LI-COR® Odyssey® CLx. Virus yield was determined by 1261 
TCID50. For strand-specific qPCR detection of MNV RNA, total cellular RNA was 1262 
extracted using GeneElute Mammalian Total RNA Miniprep kit (Sigma). RT-qPCR 1263 
was performed as described previously (Vashist et al., 2012a). 1264 
 1265 
Purification of MNV VPg-linked RNA. BV2 cells were infected at an MOI=0.01 1266 
TCID50 per cell and harvested after ~30 post infection. Cell debris was removed by 1267 
low speed centrifugation for 10 minutes and supernatant loaded onto 5 ml of 30% 1268 
sucrose solution in PBS. MNV particles were pelleted using a SW32Ti rotor at 1269 
25,000 RPM for 4 hours at 4 ℃. Virus was then resuspended in PBS and total RNA 1270 
extracted from soluble fraction. Where detailed, the authenticity of the viral RNA was 1271 
examined by nuclease digestion. 500 ng of viral RNA or plasmid DNA was treated 1272 
with DNase I (10U, Roche), XrnI+RppH (1U XrnI + 5U RppH, both from NEB) or 1273 
RNase cocktail (0.5U RNase A + 20U RNase T1, ThermoFisher) at 37 ℃ for 10 1274 
minutes. Then analysed on 1% agarose gel. 1275 
 1276 
Preparation of BV2 S10 cytoplasmic extracts. Preparation of BV2 S10 extracts 1277 
was based on a previously published protocol (Rakotondrafara and Hentze, 2011; 1278 
2006). BV2 cells were harvested, washed with PBS, and lysed with 1x packed 1279 
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volume of hypotonic buffer containing 10 mM HEPES pH7.6, 10 mM potassium 1280 
acetate, 0.5 mM magnesium acetate, 5 mM DTT, 1x protease inhibitors cocktail 1281 
(EDTA-free, Roche). Cells were lysed on ice for 45 minutes, then passed through 1282 
25G and 27G needles to achieve >95% lysis. Cell lysates were then centrifuged at 1283 
10,000 x g for 10 minutes at 4 ℃ twice and the supernatant collected. The total 1284 
protein concentration was measured by Bradford assay and normalised to 20 mg/ml 1285 
before freezing at -80 ℃ until use. For micrococcal nuclease treatment, S10 extracts 1286 
were thawed on ice, 1 mM calcium chloride and 200 unit/ml final concentrations of 1287 
micrococcal nuclease (NEB). Cell lysates were incubated at 25 ℃ for 15 minutes 1288 
before adding 3 mM final concentration of EGTA was added. 1289 
 1290 
In vitro translation of BV2 S10 lysates. In vitro translation assays were set up 1291 
based on a previous protocol (Favre and Trepo, 2001). Translation reactions were 1292 
set up in 12.5 μl total volume containing 5 μl BV2 S10 lysate, 2.5 μl 5X translation 1293 
buffer, 0.25 μl of 5 mg/ml creatine kinase, 1.25 μl RRL, 0.225 μl of 5 M potassium 1294 
acetate, 0.25 mM of 100 mM magnesium acetate, 5.13 μCi 35S-labelled methionine 1295 
(PerkinElmer) and 10-100 ng/μl RNA as detailed in the text. 5X translation buffer 1296 
contains 350 mM HEPES, 75 mM creatine phosphate, 10 mM ATP, 3.75 mM GTP, 1297 
100 μM amino acid minus methionine, 3.75 mM spermidine and 0.375 mM S-1298 
adenosyl-methionine. For control experiments using RRL (Promega), the reactions 1299 
were set up according to manufacturer’s instructions using 0.5-1 ng/μl RNA. 1300 
Reactions were incubated at 30 ℃ for 90 minutes before addition of 12.5 μl trans-1301 
stop buffer containing 10 mM EDTA and 0.1 mg/ml RNase A and incubated at room 1302 
temperature for 10 minutes, then 25 μl 5X loading buffer was added to the reaction 1303 
and heated at 95 ℃ for 5 minutes. 10 μl lysates were resolved in 15% SDS-PAGE 1304 
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and exposed to a phosphorimager screen and visualised using a TyphoonFLA7000 1305 
machine. For non-radioactive translation, 1.25 μl of 1 mM methionine was used 1306 
instead of 35S-labelled methionine, and the reactions were stopped with 100 μl 1x 1307 
passive lysis buffer (Promega) and the luminescence read using a GloMax 1308 
luminometer (Promega). 1309 
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